For research use only. Not for therapeutic Use.
ITMN 4077（Cat No.:I029653）is a small molecule inhibitor that targets specific pathways involved in immune cell signaling, with potential applications in cancer immunotherapy. It works by modulating the activity of immune receptors, aiming to enhance the body’s immune response against tumor cells. ITMN 4077 has shown promise in preclinical studies for treating cancers such as solid tumors by stimulating anti-tumor immunity. Research is ongoing to further evaluate its efficacy, safety, and ability to improve outcomes in combination with other cancer therapies, particularly in enhancing immune surveillance and tumor destruction.
| CAS Number | 790305-05-4 |
| Synonyms | tert-butyl N-[(1S,4R,6S,7Z,14S,18R)-4-(cyclopropylsulfonylcarbamoyl)-18-hydroxy-2,15-dioxo-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-en-14-yl]carbamate |
| Molecular Formula | C26H40N4O8S |
| Purity | ≥95% |
| IUPAC Name | tert-butyl N-[(1S,4R,6S,7Z,14S,18R)-4-(cyclopropylsulfonylcarbamoyl)-18-hydroxy-2,15-dioxo-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-en-14-yl]carbamate |
| InChI | InChI=1S/C26H40N4O8S/c1-25(2,3)38-24(35)27-19-10-8-6-4-5-7-9-16-14-26(16,23(34)29-39(36,37)18-11-12-18)28-21(32)20-13-17(31)15-30(20)22(19)33/h7,9,16-20,31H,4-6,8,10-15H2,1-3H3,(H,27,35)(H,28,32)(H,29,34)/b9-7-/t16-,17-,19+,20+,26-/m1/s1 |
| InChIKey | MXGKXZHTCMUVEE-JXUUZEIMSA-N |
| SMILES | CC(C)(C)OC(=O)N[C@H]1CCCCC/C=C\[C@@H]2C[C@]2(NC(=O)[C@@H]3C[C@H](CN3C1=O)O)C(=O)NS(=O)(=O)C4CC4 |
